NITRIC OXIDE TRANSDUCTION MECHANISMS IN UTIS AND IC
NITRIC OXIDE TRANSDUCTION MECHANISMS IN UTIS AND IC
批准号:
6362990
负责人:
ROBERT M WEISS
金额:
$26.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-30 至 2003-02-28
关键词:
bacterial toxicology cell type cytokine enzyme activity enzyme mechanism female gene expression gene targeting genetically modified animals human subject inflammation interstitial cystitis laboratory mouse laboratory rat neutrophil nitric oxide nitric oxide synthase pathologic process phagocytosis posttranslational modifications prostaglandins protein localization transfection urinalysis urinary tract infection
中文摘要
描述(改编自申请者摘要):尿路
感染(UTIs)和间质性膀胱炎(IC)是两种病理
主要影响女性的泌尿系统状况
有医学、心理学、社会学和经济学方面的影响。这个
这一提议的统一假设是,一氧化氮(NO),一个小的
亲脂性气体分子,从非肾上腺素能释放出来,
非胆碱能神经元,在多种哺乳动物中合成
包括巨噬细胞和中性粒细胞在内的组织在尿路感染中起中介作用。
和IC。申请人已经:1)证明了一氧化氮合酶(NOS)
慢性支气管炎患者尿液中活性和cGMP水平升高
尿路感染和IC患者尿液中的减少;2)提供第一
生物活性物质存在的确凿的分子证据
中性粒细胞感染过程中诱导型一氧化氮合酶(INOS)的表达
3)血管内皮细胞瘤患者应用L精氨酸后,一氧化氮合酶水平升高
活动和尿环GMP和NOx(硝酸盐加亚硝酸盐)水平,以及
导致IC相关症状的减少。为了检验他们的假设,他们
计划:1)确定因素,包括细胞因子和细菌产物,
在分离的人类中性粒细胞中调节一氧化氮的产生,
为了确定中性粒细胞是否以及如何产生NO参与了
吞噬和杀菌;2)鉴定炎症因子,
即细菌产物和细胞因子、酶反应和细胞类型,
参与诱导型一氧化氮合酶的表达
对尿路炎症/感染过程的修复性反应
3)表征亚细胞定位和定位。
调节人诱导型一氧化氮合酶(HiNOS)表达的翻译修饰
使用体外异源系统;以及4)确定关系
炎症细胞特性、一氧化氮、前列腺素和细胞因子之间的关系
生产,以及IC相关症状。数据的解释
所获得的不仅与He的感染/炎症过程有关
尿路,但也将有助于了解过程在
不太容易接受调查的人类。
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Urinary tract
infections (UTIs) and interstitial cystitis (IC) are two pathologic
conditions of the urinary system which predominately affect women and which
have medical, psychological, sociological and economic implications. The
unifying hypothesis of this proposal is that nitric oxide (NO), a small
lipophilic gaseous molecule, which is released from non-adrenergic,
non-cholinergic neurons and which is synthesized in a variety of mammalian
tissues including macrophages and neutrophils, acts as a mediator in UTIs
and IC. The applicants have: 1) shown that nitric oxide synthase (NOS)
activity and cyclic GMP levels are elevated in the urine of patients with a
UTI and decreased in the urine of patients with IC; 2) providing the first
definitive molecular evidence for the presence of a biologically active
inducible NOS (iNOS) in human neutrophils during an infectious process; and
3) shown that L-arginine administration to IC patients increases NOS
activity and urinary cyclic GMP and Nox (nitrate plus nitrite) levels, and
results in a decrease in IC related symptoms. To test their hypothesis they
plan to: 1) determine factors, including cytokines and bacterial products,
that mediate the production of nitric oxide in isolated human neutrophils,
and to determine if and how neutrophil produced NO is involved in
phagocytosis and bacterial killing; 2) identify the inflammatory agents,
i.e., bacterial products and cytokines, enzymatic reactions, and cell types,
that are involved in the induction of NOS during the initiation of and
reparative response to inflammatory/infectious processes in the urinary
tract; 3) characterize the subcellular localization and the post
translational modifications that regulate human iNOS (hiNOS) expression
using an in vitro heterologous system; and 4) determine the relationship
between inflammatory cell identity, nitric oxide, prostaglandin and cytokine
production, and IC related symptoms. The interpretation of the data
obtained will not only pertain to infectious/inflammatory processes of he
urinary tract, but also will facilitate the understanding of processes in
humans which are less amenable to investigation.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cyclooxygenase-2 protein and prostaglandin E(2) production are up-regulated in a rat bladder inflammation model.
在大鼠膀胱炎症模型中,Cyclooxygenase-2 蛋白和前列腺素 E(2) 的产生上调。
DOI:
10.1016/s0014-2999(01)00911-6
发表时间:
2001
期刊:
European journal of pharmacology
影响因子:
5
作者:
[Wheeler,MA, Yoon,JH, Olsson,LE, Weiss,RM]
通讯作者:
Weiss,RM
Vectors for a 'double-tagging' assay for protein-protein interactions: localization of the CDK2-binding domain of human p21.
用于蛋白质-蛋白质相互作用“双标记”测定的载体:人 p21 的 CDK2 结合域的定位。
DOI:
10.1016/0378-1119(96)00218-1
发表时间:
1996
期刊:
Gene
影响因子:
3.5
作者:
[Wang,ZX, Bhargava,A, Sarkar,R, Germino,FJ]
通讯作者:
Germino,FJ
Age-dependent changes in particulate and soluble guanylyl cyclase activities in urinary tract smooth muscle.
泌尿道平滑肌颗粒和可溶性鸟苷酸环化酶活性的年龄依赖性变化。
DOI:
10.1023/a:1006823611864
发表时间:
1997
期刊:
Molecular and cellular biochemistry
影响因子:
4.3
作者:
[Wheeler,MA, Pontari,M, Dokita,S, Nishimoto,T, Cho,YH, Hong,KW, Weiss,RM]
通讯作者:
Weiss,RM
Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder.
膀胱灌注和腹腔注射大肠杆菌脂多糖上调大鼠膀胱细胞因子和iNOS。
DOI:
--
发表时间:
1998
期刊:
The Journal of pharmacology and experimental therapeutics.
影响因子:
--
作者:
[Olsson,LE, Wheeler,MA, Sessa,WC, Weiss,RM]
通讯作者:
Weiss,RM
DOI:
10.1540/jsmr.41.1
发表时间:
2005
期刊:
Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi
影响因子:
--
作者:
[Wheeler,MarciaA, Ayyagari,RajasekharaR, Wheeler,GeorgeL, Weiss,RobertM]
通讯作者:
Weiss,RobertM
共 6 条
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
-
批准号:10216324
-
项目类别:
-
资助金额:$44.75万
-
财政年份:2018
-
负责人:ROBERT M WEISS
-
依托单位:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
-
批准号:10452547
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2018
-
负责人:ROBERT M WEISS
-
依托单位:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
-
批准号:9977238
-
项目类别:
-
资助金额:$45.13万
-
财政年份:2018
-
负责人:ROBERT M WEISS
-
依托单位:
Propagation and Resolution of Injury in Calcific Aortic Valve Disease
-
批准号:9762207
-
项目类别:
-
资助金额:$45.49万
-
财政年份:2018
-
负责人:ROBERT M WEISS
-
依托单位:
High-Resolution Research Ultrasound
-
批准号:8824742
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2015
-
负责人:ROBERT M WEISS
-
依托单位:
Research Ultrasound Imaging Upgrades
-
批准号:7784169
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:ROBERT M WEISS
-
依托单位:
Targeted siRNA nanotechnology for intravesical treatment of urologicaldiseases
-
批准号:7938678
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2009
-
负责人:ROBERT M WEISS
-
依托单位:
Targeted siRNA nanotechnology for intravesical treatment of urologicaldiseases
-
批准号:7832079
-
项目类别:
-
资助金额:$49.86万
-
财政年份:2009
-
负责人:ROBERT M WEISS
-
依托单位:
Encapsulated siRNAs for treatment of urological disease
-
批准号:7481032
-
项目类别:
-
资助金额:$24.33万
-
财政年份:2007
-
负责人:ROBERT M WEISS
-
依托单位:
Encapsulated siRNAs for treatment of urological disease
-
批准号:7238990
-
项目类别:
-
资助金额:$20.63万
-
财政年份:2007
-
负责人:ROBERT M WEISS
-
依托单位:
CARDIOVASCULAR PHENOTYPING IN MICE
-
批准号:6846333
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2003
-
负责人:ROBERT M WEISS
-
依托单位:
CARDIOVASCULAR PHENOTYPING IN MICE
-
批准号:6617030
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2003
-
负责人:ROBERT M WEISS
-
依托单位:
CARDIOVASCULAR PHENOTYPING IN MICE
-
批准号:7028254
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2003
-
负责人:ROBERT M WEISS
-
依托单位:
CARDIOVASCULAR PHENOTYPING IN MICE
-
批准号:6708871
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2003
-
负责人:ROBERT M WEISS
-
依托单位:
CARDIOVASCULAR PHENOTYPING IN MICE
-
批准号:7196532
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2003
-
负责人:ROBERT M WEISS
-
依托单位:
Murine Cardiovascular MRI
-
批准号:6580263
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2003
-
负责人:ROBERT M WEISS
-
依托单位:
INSTRUMENTATION GRANT FOR RESEARCH ECHOCARDIOGRAPHY
-
批准号:6441011
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2002
-
负责人:ROBERT M WEISS
-
依托单位:
NITRIC OXIDE IN UTIS AND INTERSTITIAL CYSTITIS
-
批准号:3248764
-
项目类别:
-
资助金额:$22.92万
-
财政年份:1993
-
负责人:ROBERT M WEISS
-
依托单位:
NITRIC OXIDE IN UTIS AND INTERSTITIAL CYSTITIS
-
批准号:2147256
-
项目类别:
-
资助金额:$25.74万
-
财政年份:1993
-
负责人:ROBERT M WEISS
-
依托单位:
NITRIC OXIDE IN UTIS AND INTERSTITIAL CYSTITIS
-
批准号:2016761
-
项目类别:
-
资助金额:$26.73万
-
财政年份:1993
-
负责人:ROBERT M WEISS
-
依托单位:
海外基金